Showing posts with label kidney exchange. Show all posts
Showing posts with label kidney exchange. Show all posts

Monday, October 19, 2026

Kidney exchange may (re)emerge in Korea

 Kidney exchange, which was pioneered in South Korea in the late 1990's, has largely been moribund there.  But here's a call to change that.

Reemerging kidney paired donation in Korea: simultaneous two-way swaps to overcome human leukocyte antigen and anatomic barriers
Eunjeong Kang1,2, Kyung Ok Min1, Hee Gyung Kang3, Yohan Ahn3, Eun Young Song4, Ara Cho5, Ahram Han5, Sangil Min5, Jongwon Ha5,6,7, Sehoon Park2, Yong Chul Kim2, Yon Su Kim2,8, Hajeong Lee2,8  Kidney Research and Clinical Practice 2026;j.krcp.25.391. DOI: https://doi.org/10.23876/j.krcp.25.391
 
Abstract
Background
South Korea first implemented kidney paired donation (KPD) to overcome ABO-incompatible living-donor kidney transplantation. Although utilization declined as desensitization matured, persistent desensitization failure and anatomic constraints have renewed interest in KPD within a regulated framework. We report a recent single-center experience.
Methods
KPD exchanges were coordinated within an institutional registry under national supervision. We retrospectively reviewed six consecutive, simultaneous two-way exchanges (12 recipients) from 2022 to 2025. We assessed predefined desensitization failure or anticipated failure with the intended donor, compared immunologic compatibility between intended and exchange donors, and recorded perioperative desensitization, graft function, delayed graft function (DGF), and biopsy-proven acute rejection (BPAR).
Results
Five of six exchanges were undertaken for immunologic reasons. All five met criteria for desensitization failure or anticipated failure to the intended donor, with positive crossmatch and high donor-specific antibody (DSA) burden. Reassignment to the exchange donor reduced risk, lowering maximum DSA mean fluorescence intensity (MFI) from 13,228 to 1,350 and total DSA MFI from 20,542 to 2,240, although selective desensitization was still required in some recipients with residual human leukocyte antigen or ABO incompatibility. The remaining exchange addressed an anatomic constraint (adult–pediatric size mismatch). At a median follow-up of 12.2 months (range, 0.9–42.1 months), no DGF or BPAR occurred; all grafts were functioning, and the median estimated glomerular filtration rate was 66.8 mL/min/1.73 m2.
Conclusion
KPD is a safe alternative when desensitization fails or is predicted to fail, including in highly sensitized and anatomically complex candidates. These findings support renewed implementation of KPD alongside selective desensitization in Korea. 

 

Wednesday, October 14, 2026

Kidney exchange in India at a national scale: a growing consensus

There's growing consensus in India on moving towards a nationwide kidney exchange program. 

Kute V, Kumar A, Balwani M et al.
Operational guidelines for kidney swap transplantation in India: an ISOT-NOTTO Delphi consensus
The Lancet Regional Health – Southeast Asia, 2026; 0 

 

 

 Among the consensus recommendations is this one, which summarizes the general positive tone adopted for national kidney exchange.

"Each transplant center should initiate and expand swap transplantation, given that it is legal, cost-effective, yields better outcomes, and can help prevent unethical commercial transplants by improving access. Multicentric swap transplantation programmes should roll out in phases: start with intra-city exchanges, then intra-state, and eventually inter-state and national collaborations. This phased approach ensures growing scale is matched with operational readiness, providing safe, equitable, and efficient transplants across regions." 

Tuesday, October 13, 2026

The University of Cincinnati celebrates Steve Woodle

Dr. Steve Woodle, one of the pioneers of kidney exchange, is being honored in Cincinnati.  You can read of his many distinctions below, but here's a striking one: he is the "the first liver transplant recipient to perform a liver transplant."

2026 Daniel Drake Medals  The University of Cincinnati College of Medicine’s highest honor 

E. Steve Woodle, MD

Professional portrait of E. Steve Woodle, MD

E. Steve Woodle, MD

Woodle, professor of surgery and the William A. Altemeier endowed chair in surgery at the College of Medicine, is a multiorgan transplant surgeon and transplant immunologist who has spent more than four decades advancing the understanding of organ rejection and pioneering immunosuppressive therapies that have reshaped transplantation. Earlier in his career at the University of Chicago, he performed a liver transplant on a 10-day-old infant, setting a Guinness World Record for the youngest liver transplant recipient. He joined the College of Medicine in 1999 and directed the Division of Transplantation for nearly two decades, building an internationally recognized program of clinical and research excellence. In 2001, he performed Ohio’s first allogeneic islet transplant for type 1 diabetes. After undergoing his own liver transplant in 2003, Woodle returned to the operating room and became the first liver transplant recipient to perform a liver transplant.

Woodle has helped originate several therapeutic approaches now considered standard in transplantation. As a fellow, he conceived the genetic re-engineering of OKT3, the first FDA-approved monoclonal antibody — work later developed into teplizumab (Tzield), which the FDA approved in 2022 as the first immunomodulatory therapy for type 1 diabetes. He was the first investigator to introduce plasma cell-targeted therapy for a non-malignant human disease, using proteasome inhibitors to treat antibody-mediated rejection in kidney transplant recipients. He also pioneered corticosteroid-free immunosuppression, including the field’s landmark double-blind, placebo-controlled trial of early corticosteroid withdrawal. He helped conceive and establish clinical kidney exchange for incompatible living-donor pairs, publishing the field’s first peer-reviewed description in the New England Journal of Medicine in 1997. Kidney exchange now accounts for roughly one in five living-donor kidney transplants in the U.S.

His scholarship includes more than 400 scientific publications cited more than 22,000 times, and he has delivered more than 700 invited lectures and mentored generations of transplant surgeons, physicians and pharmacists. In 2025, he received the American Society of Transplantation’s Senior Achievement Award in Clinical Transplantation and was named an Ashbel Smith Distinguished Alumnus by the University of Texas Medical Branch, where he earned his medical degree.

Featured photo at top: Daniel Drake Medal. Photo/University of Cincinnati.

 

Thursday, October 8, 2026

First Hungarian 3-way kidney exchange

 Semmelweis University announces the first 3-pair kidney exchange in Hungary. (HT: Péter Biró  ).

For the first time in Hungary, Semmelweisen performed triple living donor kidney transplants within the framework of a cross-donation program
Wednesday, 7 October 2026 Posted by: Eszter Csatári-Földváry
 

"The three kidney transplant patients who received a new organ at the same time two weeks ago as part of the so-called living donor kidney exchange program at Semmelweis University are doing well. The extraordinary medical feat is the result of six hours of coordinated work by thirty health care professionals. For the first time in Hungary, triple living donor cross-donation was carried out, when the immunological or blood group incompatibility between patients and donors was bridged by the medical team by swapping the donated organs between three pairs who were strangers to each other. 

...

"Until the summer of 2025, organ exchange was only possible between two couples, the first such intervention was performed at the beginning of this year at the Clinical Center in Pécs. However, with a legislative amendment last summer, several couples can participate in the – otherwise anonymous – organ exchange, which significantly increases the likelihood of optimal pairings and thus the chance of successful kidney transplants, added Dr. Attila Szijártó. He emphasized: As the number of donor organs from the dead is limited, the importance of living donation is increasing, as it can reduce the current average waiting time of 3.5 years. "

#######

Earlier:

Wednesday, February 4, 2026 Kidney exchange comes to Hungary

 

Tuesday, September 1, 2026

Three takeaways on Moral Economics, with Lynn Thoman

 Lynn Thoman and I discuss three takeaways from Moral Economics (and hers are different than mine):

 You can listen here:

Why Doing the “Right Thing” Can Make Everything Worse 

 and you can watch as well as listen here:

"What can we do when doing the morally “right” thing produces worse outcomes?

And what if some of society’s strongest moral instincts are preventing us from solving problems we all agree are terrible?

Alvin Roth is a Stanford professor and Nobel Prize-winning economist whose work has helped redesign real-world systems, including kidney exchanges and the way doctors are matched with hospitals. His new book, Moral Economics, tackles a harder category of problems: markets and behaviors we find morally objectionable, even when banning them may create consequences we don’t want.

He discusses:

    Why nearly 100,000 Americans can be waiting for a kidney 

    What prohibitions of alcohol and heroin can teach us 

    What happened when Rhode Island accidentally legalized indoor prostitution

    Whether paying kidney donors could save lives without creating an ethically unacceptable market

    Why evidence becomes especially important when reasonable people disagree about morality

    Whether performance-enhancing drugs could eventually become as ordinary as coffee

Some policies sound obviously right when judged by their intentions. But what happens when you judge them by their actual consequences?

Roth pushes into the uncomfortable territory between those two questions: when banning something creates a black market, when changing a rule may save more lives than inventing a new technology, and what we should do when the outcome we believe is morally necessary turns out to be something we cannot actually achieve."

Sunday, August 23, 2026

Reasons to be cheerful discusses kidney exchange

 The magazine Reasons to be cheerful has a cheerful discussion of kidney exchange (which includes some reflections by Mike Rees on non-simultaneous chains):

The Chains of Generosity Transforming Kidney Donation
More than 90,000 people in the U.S. are on the waitlist for a kidney transplant. How many of their lives could be saved by strangers?  By: Anna Patton 

 "Momentum is building in the U.S. behind the proposed End Kidney Deaths Act, which would provide a refundable tax credit of $50,000 to those who donate a kidney to a stranger. Campaigners say this would remove financial barriers to donating, which include loss of income during testing, surgery and recovery — while saving the billions of dollars currently spent on dialysis. "

Wednesday, August 19, 2026

Deceased-donor initiated kidney exchange chaiins in Italy, after six years

 Kidney exchange in Italy is now making good use of deceased-donor initiated chains.

 

American Journal of Transplantation

Available online 10 August 2026
American Journal of Transplantation

Original Article
Integrating Deceased and Living Donation: Six-Year Outcomes of the Italian Deceased-Donor–Initiated Kidney Paired Exchange (DEC-K) Program

 ABSTRACT
Using a deceased donor (DD) to initiate living-donor (LD) exchange chains can expand access to kidney transplantation in recipients with an HLA or ABO incompatible living donor. The Italian DD-initiated Kidney Paired Exchange (DEC-K) program uses a DD kidney to start a chain among incompatible pairs, ultimately returning a LD kidney to the waiting list. We report the first long-term analysis of this approach worldwide. All DEC-K chains performed in Italy between March 2018 and May 2025 were analyzed. Thirty-four chains generated 84 transplants (34 chain initiating kidneys CIK, 22 from LD, 28 chain-ending kidneys CEK) versus 17 transplants from conventional Kidney Paired Donation (KPD) program in the same period. Five-year outcomes were similar between CIK and LD recipients (eGFR slope: −2.0 mL/min/1.73m2/year, P=0.37; graft survival: log-rank P=0.28). While this approach diverts blood-group O DD kidneys from the general waiting list, potentially affecting non-sensitized candidates, it was designed to address the unmet needs of highly sensitized patients facing years of waiting. In the Italian setting, the DEC-K program successfully initiates LD chains from DD kidneys with outcomes equivalent to LD transplant; implementation should include monitoring of blood-group-specific outcomes and flexible design to accommodate healthcare system priorities.

... 

 "DISCUSSION
The six-year DEC-K experience demonstrates that DD-initiated KPD chains are highly effective in small national pools such as Italy’s, which include about 70 incompatible pairs at a time. Because closed-loop exchanges rarely provide enough matches, especially for blood group O or highly sensitized recipients, open chains initiated by DDs can convert a single graft into multiple sequential transplants without simultaneous multi-center surgery. In our program, 34 DDs generated 84 transplants, corresponding to a threefold increase compared to conventional loops in the Italian KPD. Broader enrollment could further enhance impact, although participation remains limited by concerns about receiving a DD kidney while the paired LD proceeds, underscoring the need for transparent counseling and clear communication about outcomes and equity.
The rationale for DEC-K aligns with models proposed by Melcher and later implemented by Furian, in which a SCD kidney is allocated to an incompatible pair whose LD subsequently donates to another recipient, propagating the chain21, 23, 29. Similar donor-driven chains were pioneered in the United States, where Rees demonstrated that a single altruistic donor could initiate a ten-transplant sequence14. Mathematical modeling by Wang et al.23 supports this approach, showing that allocating just 2-3% of DD to initiate KPD chains could generate several hundred additional transplants annually, with maximum benefit for highly sensitized and blood-group O candidates23. In countries with rare or restricted altruistic donation and small KPD pools, such as Italy, DD initiation is the only practical way to generate compatible matches. Over the past decade, only ten non-directed donors enabled 30 transplants and unlocked 21 incompatible pairs, substantially fewer than DEC-K.

##########

Earlier: 

Monday, April 11, 2016  Using deceased donor kidneys to start living donor kidney exchange chains

 

Thursday, August 13, 2026

The Paradox of Protection: Overregulation Threatens Living Kidney Donation in Mexico,

 Protections intended to thwart organ trafficking may inadvertently also "protect" legitimate patients and donors from receiving life-saving medical care.

The Paradox of Protection: How Overregulation Threatens Living Kidney Donation in Mexico, by Francisco J. Reyna-Sepulveda and Javier Sanchez-Maldonado, Transplantation, Publish Ahead of Print, July 27, 2026. | DOI: 10.1097/TP.0000000000005860 

 

 

"Globally, unrelated and nondirected living kidney donations have become important mechanisms for expanding transplant access.1 Structured programs in the United States and Spain support unrelated donation through rigorous psychological evaluation, independent donor advocacy, and transparent oversight systems.3,4 For example, nondirected donors serve as critical initiators of kidney paired donation chains, substantially amplifying transplant opportunities beyond a single donor-recipient pair.3-5 However, a recent regulatory shift in Mexico threatens to effectively preclude these pathways in practice, leaving living kidney donors (including living liver donors) with genuine altruistic intent declined and vulnerable patients losing critical access to life-saving transplants.

"WHEN ALTRUISM REQUIRES PROOF
"On August 4, 2023, the National Transplant Center and the Federal Commission for Protection against Health Risks issued a High Health Directive (Alta Directiva Sanitaria), establishing mandatory standardized protocols for Mexican transplant centers.6 This directive emerged in response to well-documented regional concerns regarding organ trafficking, transplant tourism, regulatory gaps, and the “legal simulation” of donor-recipient relationships. These concerns are entirely legitimate and align with the principles articulated by the Declaration of Istanbul on Organ Trafficking and Transplant Tourism.7 

...

"Although the directive does not explicitly outlaw nondirected donation, its evidentiary requirements effectively preclude it at the committee level. As a result, viable donor candidates may be categorically declined for regulatory rather than medical reasons.  

...

"Although data isolating the exact proportion of donor evaluations declined solely for documentation rather than medical or psychosocial factors are currently unavailable, Mexican National Registry data highlight a concerning sign.9 During the 12 mo preceding the directive’s publication, 438 unrelated living donor kidney transplants were performed nationally, compared with 354 during the subsequent 12 mo—a 19% decline. " 

...

"This directive severely limits Mexico’s potential to establish domestic paired-exchange networks or participate in cross-border paired kidney exchanges. The Global Kidney Exchange model, for instance, incorporates pairs from middle-income countries into US-initiated chains to overcome financial and immunological barriers.10 This approach has been accompanied by ethical discussion in the transplant literature, particularly regarding concerns about potential inducements and unintended exploitation.10" 

...

"Ultimately, the critical question is not whether expanding living kidney donation should be permitted, but whether a transplant system can be considered ethically complete if a viable living kidney donor candidate is categorically declined for regulatory rather than medical reasons." 

Tuesday, August 11, 2026

Civil society, state and market by Bowles and Carlin in Annual Review of Economics

 Sam Bowles and Wendy Carlin propose that we should think of civil society as the third leg in regulating economic life, along with government and markets. (They use kidney exchange as an example to indicate what they mean.) 

The Governance Triangle: Economic interactions in civil society, the state, and the market, Bowles, Samuel; Carlin, Wendy; (2026), Annual Review of Economics. 

"Abstract: Interactions in civil society – in firms, families, neighborhoods, identity groups, and other face-to-face settings – have in common that relationships are personal and enduring, and as a result, identity and other-regarding preferences are important motivations (for better or worse). Here we add civil society to markets and states as a third form of governance of the economy, creating the governance triangle. We provide evidence that themes related to civil society have assumed substantially greater importance in economic research since the 1970s. We use a standard principal-agent model of employment in private firms to reveal three characteristics of interactions in civil society: the role of face-to-face interactions, social norms, and the private exercise of power. We show that market failures and other coordination problems can sometimes be more successfully addressed by civil society than by state or market governance. Civil society may have comparative institutional advantage where information available to state and market actors is limited, restricting the reach of complete contracts and enforceable government regulations, conditional on conflicts of interest being modest. When based on us-versus-them forms of identity, however, civil society governance may promote preferences antithetical to a liberal and democratic society." 

 

 

"To illustrate the meaning of points in the triangle, we have placed the kidney exchange model proposed by Alvin Roth and his collaborators (the red dot) in the governance triangle ((Roth et al 2006).) They designed a mechanism connecting those needing a kidney replacement to altruistic donors of kidneys. Such donors are most often an immediate family member of someone whose kidney is not a match for their loved-one needing the transplant. Roth’s algorithm enables long chains of unrelated matched donors and recipients, thereby widening access to transplants because they do not have to be conducted bilaterally (the donor giving to a particular match) and contemporaneously.


"As an illustration of the nexus of synergistic institutions in the triangle, we represent the kidney donor mechanism, the red point, by a weight of 0.3 on the state (which regulates the exchanges, including prohibiting sales), 0.2 on the market (which provides associated medical services), and 0.5 on civil society (for the centrality of altruistic and ethical motivations underlying the initial contribution of the kidney.)... By relating the characteristics of behaviour and the allocation mechanisms involved to the three pure types, other institutions and policies can be located inside the triangle."

########

Note that this representation in a triangle is in a barycentric coordinate system, which has only become a readily recognizable tool in various applications in economics in the last half century or so.  Wikipedia dates their introduction to 1827.

Wednesday, August 5, 2026

Kidney exchange in Mississippi (endorsed by celebrities)

 Mississippi Today has the story:

‘Kidney chains’ could save lives and billions of healthcare dollars, advocates say.  by Pat Boone, Robert Hays and Steve Young 

"Editor’s note: Entertainer Pat Boone, Pro Football Hall of Fame quarterback Steve Young and actor Robert Hays of “Airplane” fame signed on as authors of a guest essay provided by US Blood Donors.org for Mississippi Today on “Kidney Chains.”

"This guest essay, though, written from a national perspective is of special importance to MT Ideas since Mississippi is among the states with the highest number of kidney disease-related deaths per 100,000 adjusted for age, according to the National Center for Health Statistics.* 

"Hundreds of thousands of dialysis patients in the United States could receive lifesaving kidney transplants sooner if one simple idea became widely known: “kidney chains”— sequences of living-donor transplants that allow one donor to save multiple lives. 

The goal is simple: Make “kidney chains” a household phrase. 

Kidney chains allow living donors who are incompatible with their intended recipient to help initiate a sequence of transplants that can save multiple lives. The concept builds on Nobel Prize-recognized work** in market design and has already enabled thousands of lifesaving kidney transplants. 

 

 ########

*Figure from the NCHS 

 

###########

** The video link is to the last three minutes of this 15 minute talk from 2014

Thursday, September 18, 2014  Kidney exchange at Google Zeitgeist 2014: 15 minute video